nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—liver cancer	0.709	1	CbGaD
Felbamate—L-Phenylalanine—TAT—liver cancer	0.00584	1	CrCbGaD
Felbamate—Dyspnoea—Sorafenib—liver cancer	0.000508	0.00245	CcSEcCtD
Felbamate—Lymphadenopathy—Epirubicin—liver cancer	0.000502	0.00243	CcSEcCtD
Felbamate—Dyspepsia—Sorafenib—liver cancer	0.000502	0.00242	CcSEcCtD
Felbamate—Coma—Doxorubicin—liver cancer	0.000499	0.00241	CcSEcCtD
Felbamate—Oesophagitis—Doxorubicin—liver cancer	0.000499	0.00241	CcSEcCtD
Felbamate—Decreased appetite—Sorafenib—liver cancer	0.000496	0.00239	CcSEcCtD
Felbamate—Thrombophlebitis—Epirubicin—liver cancer	0.000495	0.00239	CcSEcCtD
Felbamate—Neoplasm—Doxorubicin—liver cancer	0.000494	0.00239	CcSEcCtD
Felbamate—Mouth ulceration—Doxorubicin—liver cancer	0.000494	0.00239	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000493	0.00238	CcSEcCtD
Felbamate—Fatigue—Sorafenib—liver cancer	0.000492	0.00237	CcSEcCtD
Felbamate—Constipation—Sorafenib—liver cancer	0.000488	0.00235	CcSEcCtD
Felbamate—Pain—Sorafenib—liver cancer	0.000488	0.00235	CcSEcCtD
Felbamate—Vascular purpura—Epirubicin—liver cancer	0.000479	0.00231	CcSEcCtD
Felbamate—Hepatic failure—Epirubicin—liver cancer	0.000477	0.0023	CcSEcCtD
Felbamate—Abnormal vision—Doxorubicin—liver cancer	0.000477	0.0023	CcSEcCtD
Felbamate—Mental disability—Doxorubicin—liver cancer	0.000474	0.00229	CcSEcCtD
Felbamate—Sepsis—Doxorubicin—liver cancer	0.000474	0.00229	CcSEcCtD
Felbamate—Gastrointestinal pain—Sorafenib—liver cancer	0.000466	0.00225	CcSEcCtD
Felbamate—Lymphadenopathy—Doxorubicin—liver cancer	0.000465	0.00224	CcSEcCtD
Felbamate—Renal failure acute—Epirubicin—liver cancer	0.000464	0.00224	CcSEcCtD
Felbamate—Thrombophlebitis—Doxorubicin—liver cancer	0.000458	0.00221	CcSEcCtD
Felbamate—Increased appetite—Epirubicin—liver cancer	0.000456	0.0022	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000456	0.0022	CcSEcCtD
Felbamate—Urticaria—Sorafenib—liver cancer	0.000453	0.00219	CcSEcCtD
Felbamate—Abdominal pain—Sorafenib—liver cancer	0.000451	0.00218	CcSEcCtD
Felbamate—Body temperature increased—Sorafenib—liver cancer	0.000451	0.00218	CcSEcCtD
Felbamate—Renal impairment—Epirubicin—liver cancer	0.00045	0.00217	CcSEcCtD
Felbamate—Dermatitis bullous—Epirubicin—liver cancer	0.000449	0.00217	CcSEcCtD
Felbamate—Purpura—Epirubicin—liver cancer	0.000445	0.00215	CcSEcCtD
Felbamate—Vascular purpura—Doxorubicin—liver cancer	0.000443	0.00214	CcSEcCtD
Felbamate—Anaphylactoid reaction—Epirubicin—liver cancer	0.000443	0.00214	CcSEcCtD
Felbamate—Hepatic failure—Doxorubicin—liver cancer	0.000441	0.00213	CcSEcCtD
Felbamate—Hypoglycaemia—Epirubicin—liver cancer	0.000439	0.00212	CcSEcCtD
Felbamate—Cardiac failure—Epirubicin—liver cancer	0.000439	0.00212	CcSEcCtD
Felbamate—Hyponatraemia—Epirubicin—liver cancer	0.00043	0.00208	CcSEcCtD
Felbamate—Renal failure acute—Doxorubicin—liver cancer	0.00043	0.00207	CcSEcCtD
Felbamate—Diplopia—Epirubicin—liver cancer	0.000429	0.00207	CcSEcCtD
Felbamate—Osteoarthritis—Epirubicin—liver cancer	0.000429	0.00207	CcSEcCtD
Felbamate—Increased appetite—Doxorubicin—liver cancer	0.000422	0.00204	CcSEcCtD
Felbamate—Migraine—Epirubicin—liver cancer	0.000422	0.00204	CcSEcCtD
Felbamate—Affect lability—Epirubicin—liver cancer	0.000422	0.00204	CcSEcCtD
Felbamate—Renal impairment—Doxorubicin—liver cancer	0.000417	0.00201	CcSEcCtD
Felbamate—Dermatitis bullous—Doxorubicin—liver cancer	0.000415	0.002	CcSEcCtD
Felbamate—Face oedema—Epirubicin—liver cancer	0.000414	0.002	CcSEcCtD
Felbamate—Purpura—Doxorubicin—liver cancer	0.000412	0.00199	CcSEcCtD
Felbamate—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00041	0.00198	CcSEcCtD
Felbamate—Asthenia—Sorafenib—liver cancer	0.000409	0.00197	CcSEcCtD
Felbamate—Cardiac arrest—Epirubicin—liver cancer	0.000408	0.00197	CcSEcCtD
Felbamate—Cardiac failure—Doxorubicin—liver cancer	0.000406	0.00196	CcSEcCtD
Felbamate—Hypoglycaemia—Doxorubicin—liver cancer	0.000406	0.00196	CcSEcCtD
Felbamate—Mood swings—Epirubicin—liver cancer	0.000406	0.00196	CcSEcCtD
Felbamate—Pruritus—Sorafenib—liver cancer	0.000403	0.00195	CcSEcCtD
Felbamate—Ataxia—Epirubicin—liver cancer	0.000403	0.00195	CcSEcCtD
Felbamate—Dehydration—Epirubicin—liver cancer	0.000399	0.00192	CcSEcCtD
Felbamate—Hyponatraemia—Doxorubicin—liver cancer	0.000398	0.00192	CcSEcCtD
Felbamate—Diplopia—Doxorubicin—liver cancer	0.000397	0.00192	CcSEcCtD
Felbamate—Osteoarthritis—Doxorubicin—liver cancer	0.000397	0.00192	CcSEcCtD
Felbamate—Affect lability—Doxorubicin—liver cancer	0.00039	0.00188	CcSEcCtD
Felbamate—Migraine—Doxorubicin—liver cancer	0.00039	0.00188	CcSEcCtD
Felbamate—Hypokalaemia—Epirubicin—liver cancer	0.00039	0.00188	CcSEcCtD
Felbamate—Diarrhoea—Sorafenib—liver cancer	0.00039	0.00188	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000386	0.00186	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000386	0.00186	CcSEcCtD
Felbamate—Face oedema—Doxorubicin—liver cancer	0.000383	0.00185	CcSEcCtD
Felbamate—Gastritis—Epirubicin—liver cancer	0.000379	0.00183	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000378	0.00183	CcSEcCtD
Felbamate—Muscular weakness—Epirubicin—liver cancer	0.000378	0.00183	CcSEcCtD
Felbamate—Cardiac arrest—Doxorubicin—liver cancer	0.000377	0.00182	CcSEcCtD
Felbamate—Dizziness—Sorafenib—liver cancer	0.000377	0.00182	CcSEcCtD
Felbamate—Mood swings—Doxorubicin—liver cancer	0.000376	0.00181	CcSEcCtD
Felbamate—Ataxia—Doxorubicin—liver cancer	0.000373	0.0018	CcSEcCtD
Felbamate—Dysphagia—Epirubicin—liver cancer	0.000371	0.00179	CcSEcCtD
Felbamate—Asthma—Epirubicin—liver cancer	0.000371	0.00179	CcSEcCtD
Felbamate—Dehydration—Doxorubicin—liver cancer	0.000369	0.00178	CcSEcCtD
Felbamate—Eosinophilia—Epirubicin—liver cancer	0.000367	0.00177	CcSEcCtD
Felbamate—Pancreatitis—Epirubicin—liver cancer	0.000363	0.00175	CcSEcCtD
Felbamate—Vomiting—Sorafenib—liver cancer	0.000363	0.00175	CcSEcCtD
Felbamate—Hypokalaemia—Doxorubicin—liver cancer	0.000361	0.00174	CcSEcCtD
Felbamate—Rash—Sorafenib—liver cancer	0.00036	0.00174	CcSEcCtD
Felbamate—Dermatitis—Sorafenib—liver cancer	0.000359	0.00173	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000357	0.00172	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000357	0.00172	CcSEcCtD
Felbamate—Headache—Sorafenib—liver cancer	0.000357	0.00172	CcSEcCtD
Felbamate—Pancytopenia—Epirubicin—liver cancer	0.000352	0.0017	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—liver cancer	0.000351	0.00169	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00035	0.00169	CcSEcCtD
Felbamate—Muscular weakness—Doxorubicin—liver cancer	0.00035	0.00169	CcSEcCtD
Felbamate—Dysuria—Epirubicin—liver cancer	0.000346	0.00167	CcSEcCtD
Felbamate—Upper respiratory tract infection—Epirubicin—liver cancer	0.000344	0.00166	CcSEcCtD
Felbamate—Asthma—Doxorubicin—liver cancer	0.000343	0.00166	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—liver cancer	0.000343	0.00166	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—liver cancer	0.000339	0.00164	CcSEcCtD
Felbamate—Nausea—Sorafenib—liver cancer	0.000339	0.00163	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—liver cancer	0.000338	0.00163	CcSEcCtD
Felbamate—Weight increased—Epirubicin—liver cancer	0.000337	0.00163	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—liver cancer	0.000336	0.00162	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—liver cancer	0.000335	0.00162	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—liver cancer	0.000334	0.00161	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—liver cancer	0.000332	0.0016	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000328	0.00158	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—liver cancer	0.000326	0.00157	CcSEcCtD
Felbamate—Jaundice—Epirubicin—liver cancer	0.000322	0.00155	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—liver cancer	0.000321	0.00155	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—liver cancer	0.000321	0.00155	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—liver cancer	0.000321	0.00155	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000319	0.00154	CcSEcCtD
Felbamate—Sweating—Epirubicin—liver cancer	0.000317	0.00153	CcSEcCtD
Felbamate—Haematuria—Epirubicin—liver cancer	0.000315	0.00152	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—liver cancer	0.000313	0.00151	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—liver cancer	0.000312	0.00151	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—liver cancer	0.000312	0.0015	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—liver cancer	0.00031	0.0015	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—liver cancer	0.00031	0.0015	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—liver cancer	0.000309	0.00149	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—liver cancer	0.000308	0.00149	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—liver cancer	0.000307	0.00148	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000303	0.00146	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—liver cancer	0.000302	0.00146	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—liver cancer	0.000298	0.00144	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—liver cancer	0.000298	0.00144	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—liver cancer	0.000297	0.00144	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—liver cancer	0.000297	0.00143	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—liver cancer	0.000297	0.00143	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—liver cancer	0.000297	0.00143	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—liver cancer	0.000297	0.00143	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—liver cancer	0.000294	0.00142	CcSEcCtD
Felbamate—Sweating—Doxorubicin—liver cancer	0.000293	0.00141	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—liver cancer	0.000291	0.00141	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—liver cancer	0.000288	0.00139	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—liver cancer	0.000287	0.00138	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—liver cancer	0.000286	0.00138	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—liver cancer	0.000285	0.00138	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—liver cancer	0.00028	0.00135	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—liver cancer	0.000279	0.00135	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—liver cancer	0.000276	0.00133	CcSEcCtD
Felbamate—Flushing—Epirubicin—liver cancer	0.000275	0.00133	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—liver cancer	0.000275	0.00133	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—liver cancer	0.000274	0.00132	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—liver cancer	0.000274	0.00132	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—liver cancer	0.000272	0.00131	CcSEcCtD
Felbamate—Chills—Epirubicin—liver cancer	0.000266	0.00128	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—liver cancer	0.000264	0.00128	CcSEcCtD
Felbamate—Alopecia—Epirubicin—liver cancer	0.000262	0.00127	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—liver cancer	0.000259	0.00125	CcSEcCtD
Felbamate—Flushing—Doxorubicin—liver cancer	0.000255	0.00123	CcSEcCtD
Felbamate—Flatulence—Epirubicin—liver cancer	0.000254	0.00123	CcSEcCtD
Felbamate—Tension—Epirubicin—liver cancer	0.000253	0.00122	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—liver cancer	0.000253	0.00122	CcSEcCtD
Felbamate—Nervousness—Epirubicin—liver cancer	0.000251	0.00121	CcSEcCtD
Felbamate—Chills—Doxorubicin—liver cancer	0.000246	0.00119	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—liver cancer	0.000243	0.00117	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—liver cancer	0.00024	0.00116	CcSEcCtD
Felbamate—Anaemia—Epirubicin—liver cancer	0.000239	0.00115	CcSEcCtD
Felbamate—Agitation—Epirubicin—liver cancer	0.000237	0.00115	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—liver cancer	0.000235	0.00114	CcSEcCtD
Felbamate—Tension—Doxorubicin—liver cancer	0.000234	0.00113	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—liver cancer	0.000234	0.00113	CcSEcCtD
Felbamate—Malaise—Epirubicin—liver cancer	0.000233	0.00112	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—liver cancer	0.000232	0.00112	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—liver cancer	0.000231	0.00112	CcSEcCtD
Felbamate—Palpitations—Epirubicin—liver cancer	0.000228	0.0011	CcSEcCtD
Felbamate—Cough—Epirubicin—liver cancer	0.000225	0.00109	CcSEcCtD
Felbamate—Hypertension—Epirubicin—liver cancer	0.000223	0.00108	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—liver cancer	0.000222	0.00107	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—liver cancer	0.000221	0.00107	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Felbamate—Myalgia—Epirubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Felbamate—Chest pain—Epirubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Felbamate—Agitation—Doxorubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Felbamate—Anxiety—Epirubicin—liver cancer	0.000219	0.00106	CcSEcCtD
Felbamate—Discomfort—Epirubicin—liver cancer	0.000217	0.00105	CcSEcCtD
Felbamate—Malaise—Doxorubicin—liver cancer	0.000215	0.00104	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—liver cancer	0.000215	0.00104	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—liver cancer	0.000214	0.00103	CcSEcCtD
Felbamate—Confusional state—Epirubicin—liver cancer	0.000212	0.00103	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—liver cancer	0.000211	0.00102	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—liver cancer	0.000211	0.00102	CcSEcCtD
Felbamate—Oedema—Epirubicin—liver cancer	0.000211	0.00102	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TNF—liver cancer	0.00021	0.00268	CbGpPWpGaD
Felbamate—Infection—Epirubicin—liver cancer	0.000209	0.00101	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—GSTA4—liver cancer	0.000209	0.00267	CbGpPWpGaD
Felbamate—Cough—Doxorubicin—liver cancer	0.000208	0.00101	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000207	0.00264	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTA2—liver cancer	0.000207	0.00264	CbGpPWpGaD
Felbamate—Thrombocytopenia—Epirubicin—liver cancer	0.000206	0.000996	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—liver cancer	0.000206	0.000996	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—TCF4—liver cancer	0.000206	0.00263	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000206	0.00263	CbGpPWpGaD
Felbamate—Tachycardia—Epirubicin—liver cancer	0.000206	0.000993	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—liver cancer	0.000204	0.000983	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000204	0.0026	CbGpPWpGaD
Felbamate—Arthralgia—Doxorubicin—liver cancer	0.000203	0.000982	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—liver cancer	0.000203	0.000982	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—liver cancer	0.000203	0.000982	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—liver cancer	0.000203	0.000978	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—liver cancer	0.000202	0.00258	CbGpPWpGaD
Felbamate—Discomfort—Doxorubicin—liver cancer	0.000201	0.00097	CcSEcCtD
Felbamate—Anorexia—Epirubicin—liver cancer	0.000201	0.00097	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTA1—liver cancer	0.0002	0.00254	CbGpPWpGaD
Felbamate—Dry mouth—Doxorubicin—liver cancer	0.000199	0.00096	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—NAT2—liver cancer	0.000197	0.00252	CbGpPWpGaD
Felbamate—Hypotension—Epirubicin—liver cancer	0.000197	0.000951	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—liver cancer	0.000197	0.000949	CcSEcCtD
Felbamate—Oedema—Doxorubicin—liver cancer	0.000195	0.000941	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—liver cancer	0.000195	0.000941	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—NAT2—liver cancer	0.000195	0.00248	CbGpPWpGaD
Felbamate—Infection—Doxorubicin—liver cancer	0.000194	0.000935	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000192	0.000927	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000191	0.00244	CbGpPWpGaD
Felbamate—Thrombocytopenia—Doxorubicin—liver cancer	0.000191	0.000922	CcSEcCtD
Felbamate—Insomnia—Epirubicin—liver cancer	0.000191	0.00092	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—liver cancer	0.00019	0.000919	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—liver cancer	0.000189	0.000913	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—liver cancer	0.000188	0.00091	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—liver cancer	0.000188	0.000907	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000187	0.00239	CbGpPWpGaD
Felbamate—Somnolence—Epirubicin—liver cancer	0.000187	0.000904	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000187	0.00238	CbGpPWpGaD
Felbamate—Anorexia—Doxorubicin—liver cancer	0.000186	0.000897	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—liver cancer	0.000185	0.000895	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TP53—liver cancer	0.000185	0.00236	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BRAF—liver cancer	0.000183	0.00234	CbGpPWpGaD
Felbamate—Decreased appetite—Epirubicin—liver cancer	0.000183	0.000884	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—liver cancer	0.000182	0.00088	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—NR1H4—liver cancer	0.000182	0.00232	CbGpPWpGaD
Felbamate—Fatigue—Epirubicin—liver cancer	0.000182	0.000877	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—liver cancer	0.000181	0.00231	CbGpPWpGaD
Felbamate—Constipation—Epirubicin—liver cancer	0.00018	0.00087	CcSEcCtD
Felbamate—Pain—Epirubicin—liver cancer	0.00018	0.00087	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTA3—liver cancer	0.000179	0.00228	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HNF4A—liver cancer	0.000179	0.00228	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—liver cancer	0.000179	0.00228	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000178	0.000858	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—GSTA3—liver cancer	0.000177	0.00225	CbGpPWpGaD
Felbamate—Insomnia—Doxorubicin—liver cancer	0.000176	0.000851	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—liver cancer	0.000175	0.000845	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000174	0.00222	CbGpPWpGaD
Felbamate—Dyspnoea—Doxorubicin—liver cancer	0.000174	0.000839	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—liver cancer	0.000174	0.000838	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—liver cancer	0.000173	0.000837	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000173	0.00221	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Epirubicin—liver cancer	0.000172	0.000832	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—liver cancer	0.000172	0.000829	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000171	0.00218	CbGpPWpGaD
Felbamate—Decreased appetite—Doxorubicin—liver cancer	0.000169	0.000818	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—RAF1—liver cancer	0.000169	0.00216	CbGpPWpGaD
Felbamate—Fatigue—Doxorubicin—liver cancer	0.000168	0.000811	CcSEcCtD
Felbamate—Urticaria—Epirubicin—liver cancer	0.000167	0.000808	CcSEcCtD
Felbamate—Constipation—Doxorubicin—liver cancer	0.000167	0.000805	CcSEcCtD
Felbamate—Pain—Doxorubicin—liver cancer	0.000167	0.000805	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—liver cancer	0.000167	0.000804	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—liver cancer	0.000167	0.000804	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000166	0.00211	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GPX3—liver cancer	0.000165	0.00211	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MTOR—liver cancer	0.000165	0.00211	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTA4—liver cancer	0.000164	0.00209	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000163	0.00208	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTA4—liver cancer	0.000161	0.00206	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ABL1—liver cancer	0.000161	0.00206	CbGpPWpGaD
Felbamate—Feeling abnormal—Doxorubicin—liver cancer	0.000161	0.000776	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTA2—liver cancer	0.00016	0.00203	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000159	0.00077	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—HPGDS—liver cancer	0.000158	0.00201	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—liver cancer	0.000157	0.00201	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BRAF—liver cancer	0.000156	0.00199	CbGpPWpGaD
Felbamate—Urticaria—Doxorubicin—liver cancer	0.000155	0.000748	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—liver cancer	0.000154	0.000744	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—liver cancer	0.000154	0.000744	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTA1—liver cancer	0.000154	0.00196	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—RAF1—liver cancer	0.000153	0.00195	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—NAT2—liver cancer	0.000152	0.00194	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—liver cancer	0.000152	0.00194	CbGpPWpGaD
Felbamate—Asthenia—Epirubicin—liver cancer	0.000151	0.00073	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—NAT2—liver cancer	0.00015	0.00191	CbGpPWpGaD
Felbamate—Pruritus—Epirubicin—liver cancer	0.000149	0.00072	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—JUN—liver cancer	0.000148	0.00188	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CTNNB1—liver cancer	0.000146	0.00187	CbGpPWpGaD
Felbamate—Diarrhoea—Epirubicin—liver cancer	0.000144	0.000696	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000143	0.00183	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BRAF—liver cancer	0.00014	0.00179	CbGpPWpGaD
Felbamate—Asthenia—Doxorubicin—liver cancer	0.00014	0.000675	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK8—liver cancer	0.00014	0.00178	CbGpPWpGaD
Felbamate—Dizziness—Epirubicin—liver cancer	0.000139	0.000673	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000139	0.00177	CbGpPWpGaD
Felbamate—Pruritus—Doxorubicin—liver cancer	0.000138	0.000666	CcSEcCtD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000137	0.00174	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000134	0.00171	CbGpPWpGaD
Felbamate—Vomiting—Epirubicin—liver cancer	0.000134	0.000647	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—liver cancer	0.000133	0.000644	CcSEcCtD
Felbamate—Rash—Epirubicin—liver cancer	0.000133	0.000641	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—liver cancer	0.000133	0.000641	CcSEcCtD
Felbamate—Headache—Epirubicin—liver cancer	0.000132	0.000637	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—HRAS—liver cancer	0.000131	0.00167	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—RAF1—liver cancer	0.00013	0.00166	CbGpPWpGaD
Felbamate—Dizziness—Doxorubicin—liver cancer	0.000129	0.000622	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—liver cancer	0.000128	0.00163	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GPX3—liver cancer	0.000128	0.00163	CbGpPWpGaD
Felbamate—Nausea—Epirubicin—liver cancer	0.000125	0.000604	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—liver cancer	0.000124	0.000598	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000123	0.00157	CbGpPWpGaD
Felbamate—Rash—Doxorubicin—liver cancer	0.000123	0.000593	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—liver cancer	0.000123	0.000593	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—KDR—liver cancer	0.000122	0.00156	CbGpPWpGaD
Felbamate—Headache—Doxorubicin—liver cancer	0.000122	0.00059	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—HPGDS—liver cancer	0.000122	0.00155	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MET—liver cancer	0.00012	0.00153	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BRAF—liver cancer	0.000119	0.00152	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000119	0.00151	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GGT1—liver cancer	0.000118	0.00151	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—RAF1—liver cancer	0.000117	0.00149	CbGpPWpGaD
Felbamate—Nausea—Doxorubicin—liver cancer	0.000116	0.000559	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—ABL1—liver cancer	0.000115	0.00147	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000113	0.00143	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000112	0.00143	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000112	0.00143	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.00011	0.0014	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000108	0.00137	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000106	0.00135	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTP1—liver cancer	0.000106	0.00135	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—liver cancer	0.000105	0.00133	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP2—liver cancer	9.99e-05	0.00127	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—RAF1—liver cancer	9.97e-05	0.00127	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	9.95e-05	0.00127	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2E1—liver cancer	9.92e-05	0.00126	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA4—liver cancer	9.85e-05	0.00126	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	9.82e-05	0.00125	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2E1—liver cancer	9.78e-05	0.00125	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—liver cancer	9.74e-05	0.00124	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	9.71e-05	0.00124	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—liver cancer	9.61e-05	0.00123	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA2—liver cancer	9.6e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	9.53e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARA—liver cancer	9.39e-05	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—liver cancer	9.32e-05	0.00119	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA1—liver cancer	9.26e-05	0.00118	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—liver cancer	9.24e-05	0.00118	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—NAT2—liver cancer	9.15e-05	0.00117	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—liver cancer	9.11e-05	0.00116	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GGT1—liver cancer	9.11e-05	0.00116	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	9.03e-05	0.00115	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—RAF1—liver cancer	8.84e-05	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KDR—liver cancer	8.73e-05	0.00111	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK14—liver cancer	8.67e-05	0.00111	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—liver cancer	8.54e-05	0.00109	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—liver cancer	8.43e-05	0.00107	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—liver cancer	8.23e-05	0.00105	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—liver cancer	8.18e-05	0.00104	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—liver cancer	8.07e-05	0.00103	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.07e-05	0.00103	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARG—liver cancer	7.76e-05	0.00099	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	7.68e-05	0.000979	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTM1—liver cancer	7.52e-05	0.000959	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—liver cancer	7.51e-05	0.000957	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—liver cancer	7.41e-05	0.000945	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—HPGDS—liver cancer	7.32e-05	0.000933	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.25e-05	0.000925	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—liver cancer	7.16e-05	0.000913	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—liver cancer	7.13e-05	0.000909	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP2—liver cancer	7.13e-05	0.000909	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—liver cancer	7.03e-05	0.000896	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	6.99e-05	0.000892	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—UGDH—liver cancer	6.91e-05	0.000881	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—liver cancer	6.74e-05	0.000859	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—EPT1—liver cancer	6.5e-05	0.000828	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HRAS—liver cancer	6.46e-05	0.000823	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RAF1—liver cancer	6.31e-05	0.000805	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TAT—liver cancer	6.16e-05	0.000785	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.97e-05	0.000761	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.88e-05	0.00075	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—liver cancer	5.73e-05	0.000731	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HRAS—liver cancer	5.49e-05	0.0007	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GGT1—liver cancer	5.48e-05	0.000698	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNB1—liver cancer	5.46e-05	0.000697	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—liver cancer	5.36e-05	0.000683	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.35e-05	0.000682	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UGDH—liver cancer	5.33e-05	0.00068	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—EPT1—liver cancer	5.01e-05	0.000639	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.92e-05	0.000627	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HRAS—liver cancer	4.87e-05	0.000621	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.85e-05	0.000619	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—liver cancer	4.81e-05	0.000613	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—liver cancer	4.76e-05	0.000607	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TAT—liver cancer	4.75e-05	0.000606	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.67e-05	0.000596	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—liver cancer	4.66e-05	0.000594	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.52e-05	0.000576	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.46e-05	0.000569	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TGFB1—liver cancer	4.41e-05	0.000563	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.29e-05	0.000546	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.23e-05	0.000539	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GLUL—liver cancer	4.19e-05	0.000534	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CPT1B—liver cancer	4.19e-05	0.000534	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—liver cancer	4.12e-05	0.000526	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—liver cancer	4.09e-05	0.000521	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NR1H4—liver cancer	4.04e-05	0.000515	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA3—liver cancer	3.97e-05	0.000506	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA4—liver cancer	3.63e-05	0.000463	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA2—liver cancer	3.54e-05	0.000451	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.5e-05	0.000446	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HRAS—liver cancer	3.48e-05	0.000443	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA1—liver cancer	3.41e-05	0.000435	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NAT2—liver cancer	3.37e-05	0.00043	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—liver cancer	3.33e-05	0.000424	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDOB—liver cancer	3.23e-05	0.000412	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CPT1B—liver cancer	3.23e-05	0.000412	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GLUL—liver cancer	3.23e-05	0.000412	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGDH—liver cancer	3.21e-05	0.000409	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NR1H4—liver cancer	3.11e-05	0.000397	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CRABP1—liver cancer	3.09e-05	0.000393	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—liver cancer	3.07e-05	0.000391	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA3—liver cancer	3.06e-05	0.00039	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—EPT1—liver cancer	3.01e-05	0.000384	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TAT—liver cancer	2.86e-05	0.000364	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA4—liver cancer	2.8e-05	0.000357	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.74e-05	0.000349	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA2—liver cancer	2.73e-05	0.000348	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HPGDS—liver cancer	2.7e-05	0.000344	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA1—liver cancer	2.63e-05	0.000336	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NAT2—liver cancer	2.6e-05	0.000332	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.5e-05	0.000319	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDOB—liver cancer	2.5e-05	0.000318	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSMD10—liver cancer	2.4e-05	0.000307	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSMA4—liver cancer	2.4e-05	0.000307	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CRABP1—liver cancer	2.38e-05	0.000304	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GOT2—liver cancer	2.34e-05	0.000298	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.14e-05	0.000273	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HPGDS—liver cancer	2.08e-05	0.000265	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.07e-05	0.000264	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYCS—liver cancer	2.06e-05	0.000262	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GOT1—liver cancer	2.02e-05	0.000257	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GGT1—liver cancer	2.02e-05	0.000257	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CPT1B—liver cancer	1.94e-05	0.000248	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GLUL—liver cancer	1.94e-05	0.000248	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.88e-05	0.00024	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NR1H4—liver cancer	1.87e-05	0.000239	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.86e-05	0.000237	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSMA4—liver cancer	1.85e-05	0.000237	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSMD10—liver cancer	1.85e-05	0.000237	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA3—liver cancer	1.84e-05	0.000235	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—liver cancer	1.81e-05	0.000231	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GOT2—liver cancer	1.8e-05	0.00023	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMOX1—liver cancer	1.79e-05	0.000228	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2E1—liver cancer	1.7e-05	0.000216	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA4—liver cancer	1.68e-05	0.000215	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—liver cancer	1.67e-05	0.000212	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.64e-05	0.000209	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA2—liver cancer	1.64e-05	0.000209	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYCS—liver cancer	1.59e-05	0.000202	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA1—liver cancer	1.58e-05	0.000202	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—liver cancer	1.58e-05	0.000201	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAT2—liver cancer	1.57e-05	0.0002	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GGT1—liver cancer	1.56e-05	0.000199	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GOT1—liver cancer	1.56e-05	0.000199	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDOB—liver cancer	1.5e-05	0.000191	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—liver cancer	1.47e-05	0.000188	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARA—liver cancer	1.44e-05	0.000184	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CRABP1—liver cancer	1.43e-05	0.000183	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—liver cancer	1.4e-05	0.000178	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMOX1—liver cancer	1.38e-05	0.000176	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—liver cancer	1.29e-05	0.000164	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HPGDS—liver cancer	1.25e-05	0.00016	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—liver cancer	1.24e-05	0.000158	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—liver cancer	1.22e-05	0.000155	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARG—liver cancer	1.19e-05	0.000152	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—liver cancer	1.14e-05	0.000145	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSMD10—liver cancer	1.12e-05	0.000142	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSMA4—liver cancer	1.12e-05	0.000142	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARA—liver cancer	1.11e-05	0.000142	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—liver cancer	1.09e-05	0.000139	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GOT2—liver cancer	1.09e-05	0.000138	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—liver cancer	1.07e-05	0.000137	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2E1—liver cancer	1.02e-05	0.00013	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1e-05	0.000128	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—liver cancer	9.55e-06	0.000122	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYCS—liver cancer	9.55e-06	0.000122	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—liver cancer	9.48e-06	0.000121	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GGT1—liver cancer	9.37e-06	0.000119	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GOT1—liver cancer	9.37e-06	0.000119	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARG—liver cancer	9.21e-06	0.000117	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—liver cancer	8.41e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—liver cancer	8.39e-06	0.000107	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMOX1—liver cancer	8.3e-06	0.000106	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—liver cancer	8.29e-06	0.000106	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—liver cancer	7.73e-06	9.86e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—liver cancer	7.33e-06	9.35e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—liver cancer	7.32e-06	9.33e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—liver cancer	6.83e-06	8.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARA—liver cancer	6.7e-06	8.55e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—liver cancer	5.78e-06	7.37e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—liver cancer	5.74e-06	7.32e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARG—liver cancer	5.54e-06	7.06e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—liver cancer	5.05e-06	6.43e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—liver cancer	4.98e-06	6.35e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—liver cancer	4.72e-06	6.02e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—liver cancer	4.46e-06	5.69e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—liver cancer	4.4e-06	5.61e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—liver cancer	3.64e-06	4.64e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—liver cancer	2.68e-06	3.42e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—liver cancer	2.19e-06	2.79e-05	CbGpPWpGaD
